UAMS basic/translational scientists transcribe cutting-edge research findings into new identification, treatment, and prevention methods for cancer, infectious disease, substance abuse and behavioral problems. Researchers work with the American Heart/Stroke Associations, Centers for Disease Control, Dept. of Defense, Food and Drug Administration, National Institutes of Health, National Science Foundation, and other national/international organizations to better the health of Arkansans.

COVID-19 Research Funding

Due to the COVID-19 pandemic hitting the world and the United States in full force, several national funding opportunities have been issued. Learn more.

UAMS COVID-19 funding is available via the Time Sensitive Research Funding.

With rapidly evolving COVID-19 research impacts, find NIH guidance and information.

UAMS Research News

  • As the presentation of many research faculty members’ academic work in national and regional meetings has been affected by COVID-19 cancellations, UAMS has created a Scholarly Product Repository to mitigate the problem. The repository provides a location to collect peer-reviewed and accepted abstracts, posters and other academic products and disseminate them. Not only will it…

  • Coronavirus Disease 2019 (COVID-19) has the attention of biomedical researchers across the globe, including at UAMS. Researchers at the UAMS Arkansas Center for Genomic Epidemiology & Medicine (ArC-GEM) are applying their comparative genomic analysis and sequencing prowess to the disease. The ArC-GEM team has also studied the Ebola virus, Zika virus, and the mumps outbreak…

  • To conduct biomedical research, scientists must be able to identify, analyze and compare proteins in biological samples. This complex process requires facilities – known as proteomics cores – that house the specialized equipment and highly trained staff required for such a task.

Want to read more stories like these? Visit the Research News archive.